Pro Share Advisors LLC Novo Cure LTD Transaction History
Pro Share Advisors LLC
- $42.5 Billion
- Q4 2024
A detailed history of Pro Share Advisors LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Pro Share Advisors LLC holds 35,115 shares of NVCR stock, worth $672,452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,115
Previous 26,519
32.41%
Holding current value
$672,452
Previous $414,000
152.66%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NVCR
# of Institutions
290Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$232 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$226 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$170 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$92.2 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$52.5 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.01B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...